Should adjuvant imatinib be used as primary treatment for gastrointestinal stromal tumors?

被引：1
|
作者：
Hohenberger, Peter [1 ]
机构：
[1] Heidelberg Univ, Fac Med, Dept Surg, Div Surg Oncol & Thorac Surg, D-68167 Mannheim, Germany
来源：
NATURE CLINICAL PRACTICE ONCOLOGY | 2008年 / 5卷 / 05期
关键词：
D O I：
10.1038/ncponc1091
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：240 / 241
页数：2
相关论文
共 50 条
  • [41] One institutional experience with imatinib mesylate in the treatment of gastrointestinal stromal tumors
    Tamas, Karin R.
    Papai, Zsuzsa
    Vegh, Eva A.
    Petranyi, Agota E.
    Szucs, Zoltan
    Rohanszky, Magda
    Aranyi, Zsuzsa
    Bodoky, Gyorgy
    ANNALS OF ONCOLOGY, 2006, 17 : 164 - 164
  • [42] Novel Insights into the Treatment of Imatinib-Resistant Gastrointestinal Stromal Tumors
    César Serrano
    Suzanne George
    Claudia Valverde
    David Olivares
    Alfonso García-Valverde
    Cristina Suárez
    Rafael Morales-Barrera
    Joan Carles
    Targeted Oncology, 2017, 12 : 277 - 288
  • [43] Nonadherence to Imatinib Treatment in Patients with Gastrointestinal Stromal Tumors: The ADAGIO Study
    Mazzeo, Filomena
    Duck, Lionel
    Joosens, Eric
    Dirix, Luc
    Focan, Christian
    Forget, Frederic
    De Geest, Sabina
    Muermans, Katja
    Van Lierde, Marie-Anne
    Macdonald, Karen
    Abraham, Ivo
    De Greve, Jacques
    ANTICANCER RESEARCH, 2011, 31 (04) : 1407 - 1409
  • [44] Novel Insights into the Treatment of Imatinib-Resistant Gastrointestinal Stromal Tumors
    Serrano, Cesar
    George, Suzanne
    Valverde, Claudia
    Olivares, David
    Garcia-Valverde, Alfonso
    Suarez, Cristina
    Morales-Barrera, Rafael
    Carles, Joan
    TARGETED ONCOLOGY, 2017, 12 (03) : 277 - 288
  • [45] Ripretinib for the treatment of advanced, imatinib-resistant gastrointestinal stromal tumors
    Liu, Wei Zhen
    Du, Yu Qiang
    Shen, Qian
    Tao, Kai Xiong
    Zhang, Peng
    JOURNAL OF DIGESTIVE DISEASES, 2023,
  • [46] Indications for pre- and postoperative treatment with imatinib for gastrointestinal stromal tumors
    Heger, U.
    Weitz, J.
    Lordick, F.
    CHIRURG, 2008, 79 (07): : 630 - 637
  • [47] A lower dosage of imatinib in patients with gastrointestinal stromal tumors with toxicity of the treatment
    Yin, Y.
    Tang, S.
    Shen, C.
    Zhang, B.
    ANNALS OF ONCOLOGY, 2016, 27 : 26 - 27
  • [48] Adverse reactions during imatinib and lansoprazole treatment in gastrointestinal stromal tumors
    Severino, G
    Chillotti, C
    De Lisa, R
    Del Zompo, M
    Ardau, R
    ANNALS OF PHARMACOTHERAPY, 2005, 39 (01) : 162 - 164
  • [49] Different factors are responsible for predicting relapses after primary tumors resection and for imatinib treatment outcomes in gastrointestinal stromal tumors
    Rutkowski, Plotr
    Debiec-Rychter, Maria
    Nowecki, Zbigniew I.
    Wozniak, Agnieszka
    Michej, Wanda
    Limon, Janusz
    Siedlecki, Janusz A.
    Doboszm, Anna Jerzak vel
    Grzesiakowska, Urszula
    Nasierowska-Guttmejer, Anna
    Sygut, Jacek
    Nyckowski, Pawel
    Krawczyk, Marek
    Ruka, Wlodzimierz
    MEDICAL SCIENCE MONITOR, 2007, 13 (11): : CR515 - CR522
  • [50] Gastrointestinal stromal tumors: chemotherapy and imatinib.
    Muler J.H.
    Baker L.
    Zalupski M.M.
    Current Oncology Reports, 2002, 4 (6) : 499 - 503
12345